Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Ronglian Technology obtains patents related to pathogenic mutation screening, enabling efficient detection of potential pathogenic variants and reducing interpretation workload.
On March 28, news reports from the National Intellectual Property Administration show that Ronglian Technology (Rights Protection) Group Co., Ltd. has applied for a patent named “Method and Related Equipment for Screening Potential Pathogenic Variants and Genes,” with authorization announcement number CN115101123B, and the authorization announcement date is March 24, 2026. The application publication number is CN115101123A, the application number is CN202210540563.4, the application publication date is March 24, 2026, and the application date is May 17, 2022. The inventors are Gong Mingtao, Cai Wenjun, Zhao Ruoyue, and Li Mingzhuang. The patent agency is Beijing Fengyason Patent Agency Co., Ltd., with patent agent Sun Xiaofeng, classification numbers G16B20/20, G16B30/10.
The patent abstract shows that this application provides a method and related equipment for screening potential pathogenic variants and genes. The method includes: obtaining the gene sequencing variant file of the subject, where the gene sequencing variant file contains variant site information; selecting a first annotation database to annotate the variant site information in the gene sequencing variant file, resulting in a variant annotation file; screening the variant site information in the variant annotation file according to predetermined variant screening conditions, resulting in a variant screening file; and selecting a second annotation database to provide supplementary annotation for the variant site information in the variant screening file, resulting in a potential pathogenic variant file. The method and related equipment provided by this application for screening potential pathogenic variants and genes have high screening efficiency, allowing for the filtering out of a large number of variants with little biological significance, while retaining more valuable variant site information, providing a solid foundation for downstream analysis, reducing the workload of interpreters, and saving time and effort.
Ronglian Technology was established on March 12, 2001, and was listed on the Shenzhen Stock Exchange on December 20, 2011. The registered address and office address are both in Beijing. It is a leading data center solution provider in China, possessing full industry chain service capabilities, providing strong support for corporate digital transformation.
Ronglian Technology is categorized in the Shenwan industry as Computer - IT Services II - IT Services III, involving concepts such as Xinchuang, digital economy, and smart government. Its main business revolves around data centers for large and medium-sized enterprises and institutions, providing a complete set of solutions and professional services from consulting and design to operation and maintenance management and subsequent upgrades.
In 2025, Ronglian Technology’s operating income reached 1.949 billion yuan, ranking first among seven companies in the industry, exceeding the industry average of 1.073 billion yuan and the median of 1.232 billion yuan, leading the second place, China COSCO Shipping Technology, with 1.806 billion yuan. In its main business, system integration accounted for 1.377 billion yuan, or 70.66%. The net profit was 20.0158 million yuan, ranking fifth in the industry, lower than the industry leader, Xingtu Measurement and Control, with 101 million yuan, and the second place, Jiu Yuan Yin Hai, with 86.2043 million yuan, slightly above the industry average of 17.5496 million yuan but below the median of 32.5426 million yuan.
Recent patent status of Ronglian Technology Group Co., Ltd. is as follows:
Disclaimer: The market has risks, and investment must be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. Any information mentioned in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcements for any discrepancies. For inquiries, please contact biz@staff.sina.com.cn.
Massive information, precise interpretation, all in the Sina Finance APP.
Editor: Xiao Lang Quick Report